RxDoctor Payments Data

Agnes Fenner

Family · Jacksonville, ILNPI 1528518602

Payments from drug & device makers

$1,719in general payments, 2019–2025

Across 75 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$502
  • Sumitomo Pharma America, Inc.$422
  • Johnson & Johnson$169
  • Olympus America Inc.$124
  • AbbVie$121
  • Pfizer$106
  • plus $276 from 8 others

What the payments were for

  • Food & beverage$1,33478%
  • Education$38522%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,719 in reported general payments places this provider in the 80th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$106,082
Medicare patients
671
Services billed
3,369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron230$188,219
GemtesaVibegron141$105,453
Mirabegron ErMirabegron42$33,625
Tamsulosin Hcl1,553$21,727
Solifenacin Succinate76$5,960
Finasteride468$5,926
Alfuzosin Hcl ErAlfuzosin Hcl198$4,252
Trospium Chloride132$4,031
Silodosin39$3,886
Cephalexin29$3,184
Testosterone14$2,316
Oxybutynin Chloride ErOxybutynin Chloride101$1,899
Methenamine Hippurate20$1,578
Terazosin Hcl88$1,082
Bethanechol Chloride47$1,024

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$502$188,219230 claims
Sumitomo Pharma America, Inc.Gemtesa$422$105,453141 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,941 family providers in Illinois.

Other family in Jacksonville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →